Establishment of the Center for Forecasting and Outbreak Analytics, 1238-1240 [2023-00151]
Download as PDF
1238
Federal Register / Vol. 88, No. 5 / Monday, January 9, 2023 / Notices
the quality, utility, and clarity of the
information to be collected, and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2023–00096 Filed 1–6–23; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Establishment of the Center for
Forecasting and Outbreak Analytics
Centers for Disease Control and
Prevention, HHS.
ACTION: Notice.
AGENCY:
The Centers for Disease
Control and Prevention (CDC) has
modified its structure. This notice
announces the establishment of the
Center for Forecasting and Outbreak
Analytics.
DATES: This reorganization was
approved by the Secretary of Health and
Human Services on December 19, 2022,
and became effective on January 4,
2023.
SUPPLEMENTARY INFORMATION: Part C
(Centers for Disease Control and
Prevention) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–76, dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 87 FR 51670–51675,
dated August 23, 2022) is amended to
reflect the reorganization of the Office of
the Director, Centers for Disease Control
and Prevention.
Background: Establishing the Center
for Forecasting and Outbreak Analytics
is the result of the National Security
Memorandum #1 (Section 5B)
indicating the need to establish an
interagency national Center and
modernize global early warning and
trigger systems to prevent, detect,
respond to, and recover from emerging
biological threats, as well as Section
2404 of the American Rescue Plan Act
of 2021, Public Law 117–2, which
provides funding in support of public
health data surveillance and analytic
infrastructure modernization initiatives
at the Centers for Disease Control and
Prevention. Specifically, the changes are
as follows:
Under Part C, Section C–B,
Organization and Functions, make the
following change:
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
18:21 Jan 06, 2023
Jkt 259001
Center for Forecasting and Outbreak
Analytics (CD)
The mission of the Center for
Forecasting and Outbreak Analytics
(CFA) is to advance U.S. forecasting,
outbreak analytics, and surveillance
capacities related to disease outbreaks,
epidemics, and pandemics to support
public health response and
preparedness. To carry out its mission,
CFA will: (1) forecast, model, and
characterize the risks associated with
outbreaks; (2) inform public health
decision-makers and the public; (3)
innovate public health solutions and
capabilities related to forecasting,
surveillance, and analytics; (4)
accelerate access to and use of data for
public health decision-makers to
mitigate the effects of disease threats;
and (5) serves as a hub for research and
development for public health analytics
and modeling.
Office of the Director (CD1)
(1) Provides strategic direction
regarding forecasting, surveillance, and
data analytics; (2) coordinates strategic
activities in areas of outbreak, epidemic
and pandemic forecasting, surveillance,
and data analytics within CDC and
across the United States Government
(USG); (3) guides the facilitation and
coordination across federal, state, tribal,
local, or territorial (STLT), and
healthcare entities and engagement with
relevant federal advisory committees
with respect to disease modeling,
forecasting, outbreak analytics, and
critical data collections to support those
efforts; (4) manages, directs,
coordinates, and evaluates the activities
of the Center; (5) defines goals and
objectives for policy formation,
scientific oversight, and guidance in
program planning and development
related to forecasting, surveillance, and
analytics; (6) provides oversight for the
evaluation of programmatic
performance of forecasting, surveillance,
and analytics; (7) manages intergovernmental and external affairs and
cultivates strategic partnerships related
to CFA activities; (8) ensures scientific
quality, integrity, and clearance across
the Center; (9) provides guidance and
strategic oversight to the processes
within the Center that access, collect,
manage, analyze, and visualize data,
including assistance for involvement
with relevant federal advisory
committees and other stakeholder
groups; (10) collaborates and consults
with other Centers, working groups,
state and local health departments,
other federal agencies, international
partners, and other partners on CFA
activities; (11) represents CFA and CDC
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
at professional and scientific meetings
on topics consistent with CFA’s
mission; and (12) establishes and
oversees the two offices within the
Office of the Director.
Office of Policy and Communications
(CD12)
(1) Provides leadership on issues
management, budget formulation, and
performance integration; (2) reviews,
coordinates, and prepares legislation,
briefing documents, Congressional
testimony, and other legislative matters;
(3) coordinates the development,
review, and approval of federal
regulations, Federal Register notices
and announcements, Freedom of
Information Act requests, General
Accounting Office and Inspector
General reports, and related activities
for the Center; and (4) establishes and
implements a communication strategy
in support of CFA overarching goals and
priorities.
Office of Management Services (CD13)
(1) Provides overall budgetary,
employee relations, human capital
management, logistics, and
administrative support; (2) provides
direction, strategy, analysis, and
operational support in all aspects of
human capital management, including
workforce and career development and
human resources operations; (3)
manages operational budget processes,
including planning, execution, and
monitoring; (4) manages acquisition and
grants management processes; (5) serves
as point of contact on all matters
concerning facilities management,
property management, records
management, equipment, travel, and
space utilization and improvements;
and (6) serves as coordinator of
continuity of operations activities.
Inform Division (CDB)
(1) Communicates with expert disease
modelers and emergency responders to
provide public health policy decision
support; (2) shares timely, actionable
information with the federal
government, STLT leaders, international
partners, and the public; (3) works with
and through public health partners to
provide decision support and technical
assistance; (4) develops, maintains,
enhances data visualization capabilities
to support CFA mission; (5) coordinates
real-time monitoring efforts between
CDC subject matter experts and USG
interagency; and (6) maintains liaison
with related Center staff, other officials
of CDC, USG, and private sector
partners.
E:\FR\FM\09JAN1.SGM
09JAN1
Federal Register / Vol. 88, No. 5 / Monday, January 9, 2023 / Notices
Office of the Director (CDB1)
(1) Works with CFA OD to ensure
spending plans and budgets are in line
with overall division strategies and
priorities; (2) ensures the CFA strategy
is executed by the Inform Division and
aligned with overall CDC goals; (3)
develops execution strategies for
outbreak communication, data
visualization, and real-time monitoring
efforts; (4) builds leadership at the
division and team levels; (5) identifies
and coordinates synergies between the
division and federal, STLT, and
international partners; (6) works directly
with public health partners to provide
decision support; (7) proposes resource
priorities throughout the budget cycle;
(8) works with CDC procurement office
to facilitate procurement opportunities
with industry partners; (9) ensures
scientific quality, integrity, and
clearance across the division; and (10)
liaises with related Center staff, other
officials of CDC, USG, and private sector
partners.
Predict Division (CDD)
(1) Generates forecasts and analyses to
support outbreak preparedness and
response efforts; (2) provides real-time
monitoring of disease outbreaks; (3)
collaborates with federal, state,
territorial, local, and tribal leaders and
international partners on performing
analytics to support decision-making;
(4) assists with tabletop exercises to
match policies and resources with
forecasts; (5) supports the development
of pandemic planning guidance; (6)
develops scientific collaborations to
harmonize analytic approaches and
develop tools; (7) maintains analytic
data sets and models during
emergencies to address questions that
arise with short latency; (8) identifies
and gains access to sources of data
relevant to outbreak analytics,
forecasting, and modeling; and (9)
builds, maintains, and improves
modeling and forecasting platforms to
be deployed during public health
emergencies, including public-facing
forecasts.
lotter on DSK11XQN23PROD with NOTICES1
Office of the Director (CDD1)
(1) Works with CFA Office of the
Director to ensure spending plans and
budgets are in line with overall division
strategies and priorities; (2) ensures the
CFA strategy is executed by the Predict
Division and aligned with overall CDC
goals; (3) develops execution strategies
for pandemic forecasting, surveillance,
and outbreak response; (4) builds
leadership at the division and team
levels; (5) evaluates the strategies, focus,
and prioritization of the division; (6)
VerDate Sep<11>2014
18:21 Jan 06, 2023
Jkt 259001
identifies and coordinates synergies
between the division and federal, STLT,
and international partners; (7) facilitates
tabletop exercises; (8) proposes resource
priorities throughout the budget cycle;
(9) works with CDC procurement office
to facilitate procurement opportunities
with industry partners; (10) ensures
scientific quality, integrity, and
clearance across the division; and (11)
oversees the development and
successful deployment of modeling and
forecasting capabilities in emergency
response situations.
Real Time Monitoring Branch (CDDB)
(1) Monitors outbreak events through
established analytical tools and
surveillance methods; (2) generates
short-term forecasts of disease spread
during an active outbreak; (3) utilizes
data of previous outbreaks to monitor
and forecast the behavior of potential
and/or current outbreaks; and (4)
generates multiple scenario models of
potential/current outbreaks using
established methodologies.
Analytics Response Branch (CDDC)
(1) Utilizes established analytical
tools to help inform decision making for
key partners during a potential and/or
current outbreak; (2) Analyzes disease
spread through existing data sources to
identify key populations/settings at
highest risk; (3) identifies potential
economic impact of a forecasted/
ongoing outbreak event; (4) provides
essential information to key partners in
decisions surrounding community
migration; (5) utilizes data analytics to
inform decisions on potential variants of
a pathogen; and (6) works with key
partners to inform decisions on medical
countermeasures during an active
outbreak.
Technology and Innovation Division
(CDE)
(1) Oversees the development,
maintenance, and improvement of
CFA’s analytical architecture; (2)
provides high-level support for CFA’s
strategic direction with respect to
technology and innovative practices; (3)
oversees product development for CFA
and CFA’s customers; (4) collaborates
with other divisions within CFA to
support research and development and
provide technical assistance on an
adhoc basis; (5) oversees the
deployment of grants and cooperative
agreements to support innovation
within the Center.
Office of the Director (CDE1)
(1) Works with CFA OD to ensure
spending plans and budgets are in line
with overall division strategies and
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
1239
priorities; (2) ensures that the CFA
strategy is executed by the Technology
& Innovation Division and aligned with
overall CDC goals; (3) develops
execution strategies for maintaining
CFA’s analytical architecture and
supporting research and development
across the division; (4) builds leadership
at the division and branch levels; (5)
coordinates with other divisions across
CFA to support modeling, code
development, and general research &
development; (6) maintains strategic
relationships with academic, private
sector, and interagency partners; (7)
works with CDC procurement office to
facilitate procurement opportunities
with industry partners; and (9) ensures
scientific quality, integrity, and
clearance across the division.
Technology Branch (CDEB)
(1) Establishes and maintains CFA
analytical architecture; (2) devises
information technology practices and
procedures, and provides direction,
innovation, planning, and evaluation for
information technology systems,
services, security, and resources for
CFA; (3) monitors projects for effective
focus on the analytical, informatics, data
management, and statistical
infrastructure to deliver timely, quality
data, accurate analysis services, and
dependable software products and
systems to customers and partners; (4)
develops, maintains, and operates
analytics technology platforms; (5)
engages in product development for
CFA systems, enterprise systems, and
analytical tools; (6) supports CFA in
modeling and general code
development, data engineering, and
software development; (7) enables cloud
environment architecture, development,
deployment, and access; (8) supports
CDC, USG efforts to maintain, enhance,
and develop relevant systems that will
address the CFA mission; and (9)
maintains awareness of trends in
technology and evaluates technology
that would benefit the CFA mission.
Innovate Branch (CDEC)
(1) Supports research and
development to improve outbreak
forecasts and analyses; (2) collaborates
with academic, private sector, and
interagency partners; (3) creates
translational tools, products, and
enterprise enhancements to make
analyses of pandemic data flexible, fast,
and scalable for CFA customers
including STLT authorities; (4) provides
grants and cooperative agreements to
support innovations in data analytics
and modeling.
E:\FR\FM\09JAN1.SGM
09JAN1
1240
Federal Register / Vol. 88, No. 5 / Monday, January 9, 2023 / Notices
Delegations of Authority
All delegations and redelegations of
authority made to officials and
employees of affected organizational
components will continue in them or
their successors pending further
redelegation, provided they are
consistent with this reorganization.
(Authority: 44 U.S.C. 3101)
Xavier Becerra,
Secretary of Health and Human Services.
Dated: January 3, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–00143 Filed 1–6–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Interagency Coordinating Committee
on the Validation of Alternative
Methods Communities of Practice
Webinar on Emerging Approaches for
Anchoring Biological Relevance of
New Approach Methodologies; Notice
of Public Webinar; Registration
Information
[FR Doc. 2023–00151 Filed 1–6–23; 8:45 am]
BILLING CODE 4160–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
The Interagency Coordinating
Committee on the Validation of
Alternative Methods (ICCVAM)
announces a public webinar ‘‘Emerging
Approaches for Anchoring Biological
Relevance of New Approach
Methodologies.’’ The webinar is
organized on behalf of ICCVAM by the
National Toxicology Program
Interagency Center for the Evaluation of
Alternative Toxicological Methods
(NICEATM). Interested persons may
participate via the web meeting
platform. Time will be allotted for
questions from the audience.
Information about the webinar and
registration are available at https://
ntp.niehs.nih.gov/go/commprac-2023.
DATES:
Webinar: January 30, 2023, 10:00 a.m.
to approximately 12:00 noon EST.
Registration for Webinar: January 10,
2023, until 12:00 noon EST January 30,
2023. Registration to view the webinar
is required.
ADDRESSES: Webinar web page: https://
ntp.niehs.nih.gov/go/commprac-2023.
FOR FURTHER INFORMATION CONTACT: Dr.
Nicole Kleinstreuer, Director,
NICEATM, email: nicole.kleinstreuer@
nih.gov, telephone: (984) 287–3150.
SUPPLEMENTARY INFORMATION:
Background: ICCVAM promotes the
development and validation of toxicity
testing methods that protect human
health and the environment while
replacing, reducing, or refining animal
use. ICCVAM also provides guidance to
test method developers and facilitates
collaborations that promote the
development of new test methods. To
address these goals, ICCVAM will hold
a Communities of Practice webinar on
SUMMARY:
lotter on DSK11XQN23PROD with NOTICES1
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; PHS–2023–1—NIH/NIAID
117 (Adjuvant Development for Vaccines for
Infectious and Immune-Mediated Diseases).
Date: January 25, 2023.
Time: 9:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G43,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Sandip Bhattacharyya,
Ph.D., Scientific Review Officer, Division of
Extramural Activities, National Institute of
Allergy and Infectious Diseases, National
Institutes of Health, 5601 Fishers Lane, Room
3G42, Rockville, MD 20852, (240) 292–0189,
sandip.bhattacharyya@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
VerDate Sep<11>2014
18:21 Jan 06, 2023
Jkt 259001
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
‘‘Emerging Approaches for Anchoring
Biological Relevance of New Approach
Methodologies.’’
‘‘New approach methodologies’’
(NAMs) refers to approaches that can be
used alone or in combination to provide
information on chemical hazard and
risk assessment without traditional
animal tests. Traditional approaches to
evaluating NAMs consider how well the
results of chemical tests using NAMs
correspond with the results of animal
tests of the same chemicals. However,
the usefulness of this approach is
limited, especially when the animal
results are variable, or the animal model
does not adequately represent the
species or effect of regulatory interest.
This webinar will discuss approaches
to build confidence in NAMs that are
based on evaluating the biological
relevance of the NAM to the species of
regulatory interest. Ongoing activities
and key insights will be described in
three presentations by speakers from the
academic and private sector focusing on
applications of small model organisms,
organs-on-chips, and models of
absorption, distribution, metabolism,
and excretion. The preliminary agenda
and additional information about
presentations will be posted at https://
ntp.niehs.nih.gov/go/commprac-2023 as
available.
Webinar and Registration: This
webinar is open to the public with time
scheduled for questions by participants
following each presentation.
Registration for the webinar is required.
Registration will open on or before
January 10, 2023 and remain open
through 12:00 noon EST on January 30,
2023. Registration is available at https://
ntp.niehs.nih.gov/go/commprac-2023.
Interested individuals are encouraged to
visit this web page to stay abreast of the
most current webinar information.
Registrants will receive instructions on
how to access and participate in the
webinar in the email confirming their
registration.
Background Information on ICCVAM
and NICEATM: ICCVAM is an
interagency committee composed of
representatives from 17 federal
regulatory and research agencies that
require, use, generate, or disseminate
toxicological and safety testing
information. ICCVAM conducts
technical evaluations of new, revised,
and alternative safety testing methods
and integrated testing strategies with
regulatory applicability. ICCVAM also
promotes the scientific validation and
regulatory acceptance of testing
methods that more accurately assess the
safety and hazards of chemicals and
products and replace, reduce, or refine
animal use.
E:\FR\FM\09JAN1.SGM
09JAN1
Agencies
[Federal Register Volume 88, Number 5 (Monday, January 9, 2023)]
[Notices]
[Pages 1238-1240]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-00151]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Establishment of the Center for Forecasting and Outbreak
Analytics
AGENCY: Centers for Disease Control and Prevention, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC) has
modified its structure. This notice announces the establishment of the
Center for Forecasting and Outbreak Analytics.
DATES: This reorganization was approved by the Secretary of Health and
Human Services on December 19, 2022, and became effective on January 4,
2023.
SUPPLEMENTARY INFORMATION: Part C (Centers for Disease Control and
Prevention) of the Statement of Organization, Functions, and
Delegations of Authority of the Department of Health and Human Services
(45 FR 67772-76, dated October 14, 1980, and corrected at 45 FR 69296,
October 20, 1980, as amended most recently at 87 FR 51670-51675, dated
August 23, 2022) is amended to reflect the reorganization of the Office
of the Director, Centers for Disease Control and Prevention.
Background: Establishing the Center for Forecasting and Outbreak
Analytics is the result of the National Security Memorandum #1 (Section
5B) indicating the need to establish an interagency national Center and
modernize global early warning and trigger systems to prevent, detect,
respond to, and recover from emerging biological threats, as well as
Section 2404 of the American Rescue Plan Act of 2021, Public Law 117-2,
which provides funding in support of public health data surveillance
and analytic infrastructure modernization initiatives at the Centers
for Disease Control and Prevention. Specifically, the changes are as
follows:
Under Part C, Section C-B, Organization and Functions, make the
following change:
Center for Forecasting and Outbreak Analytics (CD)
The mission of the Center for Forecasting and Outbreak Analytics
(CFA) is to advance U.S. forecasting, outbreak analytics, and
surveillance capacities related to disease outbreaks, epidemics, and
pandemics to support public health response and preparedness. To carry
out its mission, CFA will: (1) forecast, model, and characterize the
risks associated with outbreaks; (2) inform public health decision-
makers and the public; (3) innovate public health solutions and
capabilities related to forecasting, surveillance, and analytics; (4)
accelerate access to and use of data for public health decision-makers
to mitigate the effects of disease threats; and (5) serves as a hub for
research and development for public health analytics and modeling.
Office of the Director (CD1)
(1) Provides strategic direction regarding forecasting,
surveillance, and data analytics; (2) coordinates strategic activities
in areas of outbreak, epidemic and pandemic forecasting, surveillance,
and data analytics within CDC and across the United States Government
(USG); (3) guides the facilitation and coordination across federal,
state, tribal, local, or territorial (STLT), and healthcare entities
and engagement with relevant federal advisory committees with respect
to disease modeling, forecasting, outbreak analytics, and critical data
collections to support those efforts; (4) manages, directs,
coordinates, and evaluates the activities of the Center; (5) defines
goals and objectives for policy formation, scientific oversight, and
guidance in program planning and development related to forecasting,
surveillance, and analytics; (6) provides oversight for the evaluation
of programmatic performance of forecasting, surveillance, and
analytics; (7) manages inter-governmental and external affairs and
cultivates strategic partnerships related to CFA activities; (8)
ensures scientific quality, integrity, and clearance across the Center;
(9) provides guidance and strategic oversight to the processes within
the Center that access, collect, manage, analyze, and visualize data,
including assistance for involvement with relevant federal advisory
committees and other stakeholder groups; (10) collaborates and consults
with other Centers, working groups, state and local health departments,
other federal agencies, international partners, and other partners on
CFA activities; (11) represents CFA and CDC at professional and
scientific meetings on topics consistent with CFA's mission; and (12)
establishes and oversees the two offices within the Office of the
Director.
Office of Policy and Communications (CD12)
(1) Provides leadership on issues management, budget formulation,
and performance integration; (2) reviews, coordinates, and prepares
legislation, briefing documents, Congressional testimony, and other
legislative matters; (3) coordinates the development, review, and
approval of federal regulations, Federal Register notices and
announcements, Freedom of Information Act requests, General Accounting
Office and Inspector General reports, and related activities for the
Center; and (4) establishes and implements a communication strategy in
support of CFA overarching goals and priorities.
Office of Management Services (CD13)
(1) Provides overall budgetary, employee relations, human capital
management, logistics, and administrative support; (2) provides
direction, strategy, analysis, and operational support in all aspects
of human capital management, including workforce and career development
and human resources operations; (3) manages operational budget
processes, including planning, execution, and monitoring; (4) manages
acquisition and grants management processes; (5) serves as point of
contact on all matters concerning facilities management, property
management, records management, equipment, travel, and space
utilization and improvements; and (6) serves as coordinator of
continuity of operations activities.
Inform Division (CDB)
(1) Communicates with expert disease modelers and emergency
responders to provide public health policy decision support; (2) shares
timely, actionable information with the federal government, STLT
leaders, international partners, and the public; (3) works with and
through public health partners to provide decision support and
technical assistance; (4) develops, maintains, enhances data
visualization capabilities to support CFA mission; (5) coordinates
real-time monitoring efforts between CDC subject matter experts and USG
interagency; and (6) maintains liaison with related Center staff, other
officials of CDC, USG, and private sector partners.
[[Page 1239]]
Office of the Director (CDB1)
(1) Works with CFA OD to ensure spending plans and budgets are in
line with overall division strategies and priorities; (2) ensures the
CFA strategy is executed by the Inform Division and aligned with
overall CDC goals; (3) develops execution strategies for outbreak
communication, data visualization, and real-time monitoring efforts;
(4) builds leadership at the division and team levels; (5) identifies
and coordinates synergies between the division and federal, STLT, and
international partners; (6) works directly with public health partners
to provide decision support; (7) proposes resource priorities
throughout the budget cycle; (8) works with CDC procurement office to
facilitate procurement opportunities with industry partners; (9)
ensures scientific quality, integrity, and clearance across the
division; and (10) liaises with related Center staff, other officials
of CDC, USG, and private sector partners.
Predict Division (CDD)
(1) Generates forecasts and analyses to support outbreak
preparedness and response efforts; (2) provides real-time monitoring of
disease outbreaks; (3) collaborates with federal, state, territorial,
local, and tribal leaders and international partners on performing
analytics to support decision-making; (4) assists with tabletop
exercises to match policies and resources with forecasts; (5) supports
the development of pandemic planning guidance; (6) develops scientific
collaborations to harmonize analytic approaches and develop tools; (7)
maintains analytic data sets and models during emergencies to address
questions that arise with short latency; (8) identifies and gains
access to sources of data relevant to outbreak analytics, forecasting,
and modeling; and (9) builds, maintains, and improves modeling and
forecasting platforms to be deployed during public health emergencies,
including public-facing forecasts.
Office of the Director (CDD1)
(1) Works with CFA Office of the Director to ensure spending plans
and budgets are in line with overall division strategies and
priorities; (2) ensures the CFA strategy is executed by the Predict
Division and aligned with overall CDC goals; (3) develops execution
strategies for pandemic forecasting, surveillance, and outbreak
response; (4) builds leadership at the division and team levels; (5)
evaluates the strategies, focus, and prioritization of the division;
(6) identifies and coordinates synergies between the division and
federal, STLT, and international partners; (7) facilitates tabletop
exercises; (8) proposes resource priorities throughout the budget
cycle; (9) works with CDC procurement office to facilitate procurement
opportunities with industry partners; (10) ensures scientific quality,
integrity, and clearance across the division; and (11) oversees the
development and successful deployment of modeling and forecasting
capabilities in emergency response situations.
Real Time Monitoring Branch (CDDB)
(1) Monitors outbreak events through established analytical tools
and surveillance methods; (2) generates short-term forecasts of disease
spread during an active outbreak; (3) utilizes data of previous
outbreaks to monitor and forecast the behavior of potential and/or
current outbreaks; and (4) generates multiple scenario models of
potential/current outbreaks using established methodologies.
Analytics Response Branch (CDDC)
(1) Utilizes established analytical tools to help inform decision
making for key partners during a potential and/or current outbreak; (2)
Analyzes disease spread through existing data sources to identify key
populations/settings at highest risk; (3) identifies potential economic
impact of a forecasted/ongoing outbreak event; (4) provides essential
information to key partners in decisions surrounding community
migration; (5) utilizes data analytics to inform decisions on potential
variants of a pathogen; and (6) works with key partners to inform
decisions on medical countermeasures during an active outbreak.
Technology and Innovation Division (CDE)
(1) Oversees the development, maintenance, and improvement of CFA's
analytical architecture; (2) provides high-level support for CFA's
strategic direction with respect to technology and innovative
practices; (3) oversees product development for CFA and CFA's
customers; (4) collaborates with other divisions within CFA to support
research and development and provide technical assistance on an adhoc
basis; (5) oversees the deployment of grants and cooperative agreements
to support innovation within the Center.
Office of the Director (CDE1)
(1) Works with CFA OD to ensure spending plans and budgets are in
line with overall division strategies and priorities; (2) ensures that
the CFA strategy is executed by the Technology & Innovation Division
and aligned with overall CDC goals; (3) develops execution strategies
for maintaining CFA's analytical architecture and supporting research
and development across the division; (4) builds leadership at the
division and branch levels; (5) coordinates with other divisions across
CFA to support modeling, code development, and general research &
development; (6) maintains strategic relationships with academic,
private sector, and interagency partners; (7) works with CDC
procurement office to facilitate procurement opportunities with
industry partners; and (9) ensures scientific quality, integrity, and
clearance across the division.
Technology Branch (CDEB)
(1) Establishes and maintains CFA analytical architecture; (2)
devises information technology practices and procedures, and provides
direction, innovation, planning, and evaluation for information
technology systems, services, security, and resources for CFA; (3)
monitors projects for effective focus on the analytical, informatics,
data management, and statistical infrastructure to deliver timely,
quality data, accurate analysis services, and dependable software
products and systems to customers and partners; (4) develops,
maintains, and operates analytics technology platforms; (5) engages in
product development for CFA systems, enterprise systems, and analytical
tools; (6) supports CFA in modeling and general code development, data
engineering, and software development; (7) enables cloud environment
architecture, development, deployment, and access; (8) supports CDC,
USG efforts to maintain, enhance, and develop relevant systems that
will address the CFA mission; and (9) maintains awareness of trends in
technology and evaluates technology that would benefit the CFA mission.
Innovate Branch (CDEC)
(1) Supports research and development to improve outbreak forecasts
and analyses; (2) collaborates with academic, private sector, and
interagency partners; (3) creates translational tools, products, and
enterprise enhancements to make analyses of pandemic data flexible,
fast, and scalable for CFA customers including STLT authorities; (4)
provides grants and cooperative agreements to support innovations in
data analytics and modeling.
[[Page 1240]]
Delegations of Authority
All delegations and redelegations of authority made to officials
and employees of affected organizational components will continue in
them or their successors pending further redelegation, provided they
are consistent with this reorganization.
(Authority: 44 U.S.C. 3101)
Xavier Becerra,
Secretary of Health and Human Services.
[FR Doc. 2023-00151 Filed 1-6-23; 8:45 am]
BILLING CODE 4160-18-P